Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShares IssuedShort-Term Debt issuances
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Bio Key International (BKYI) Depreciation & Amortization (CF) (2016 - 2025)

Bio Key International's Depreciation & Amortization (CF) history spans 16 years, with the latest figure at $21266.0 for Q3 2025.

  • For Q3 2025, Depreciation & Amortization (CF) fell 7.72% year-over-year to $21266.0; the TTM value through Sep 2025 reached $88925.0, down 16.14%, while the annual FY2024 figure was $93026.0, 23.81% up from the prior year.
  • Depreciation & Amortization (CF) for Q3 2025 was $21266.0 at Bio Key International, down from $21966.0 in the prior quarter.
  • Across five years, Depreciation & Amortization (CF) topped out at $36923.0 in Q4 2023 and bottomed at $6439.0 in Q4 2021.
  • The 5-year median for Depreciation & Amortization (CF) is $13395.0 (2023), against an average of $17453.6.
  • The largest annual shift saw Depreciation & Amortization (CF) crashed 75.81% in 2021 before it soared 269.93% in 2023.
  • A 5-year view of Depreciation & Amortization (CF) shows it stood at $6439.0 in 2021, then skyrocketed by 55.01% to $9981.0 in 2022, then skyrocketed by 269.93% to $36923.0 in 2023, then tumbled by 35.24% to $23911.0 in 2024, then decreased by 11.06% to $21266.0 in 2025.
  • Per Business Quant, the three most recent readings for BKYI's Depreciation & Amortization (CF) are $21266.0 (Q3 2025), $21966.0 (Q2 2025), and $21782.0 (Q1 2025).